Detalhe da pesquisa
1.
Nonclinical Efficacy and Safety of CX-2029, an Anti-CD71 Probody-Drug Conjugate.
Mol Cancer Ther
; 21(8): 1326-1336, 2022 08 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35666803
2.
University of California Research Seminar Network: a prospectus.
PLoS Biol
; 8(1): e1000289, 2010 Jan 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-20087412
3.
Convection-enhanced delivery of targeted quantum dot-immunoliposome hybrid nanoparticles to intracranial brain tumor models.
Nanomedicine (Lond)
; 8(12): 1913-25, 2013 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-23631502
4.
Challenges in drug delivery to tumors of the central nervous system: an overview of pharmacological and surgical considerations.
Adv Drug Deliv Rev
; 64(7): 590-7, 2012 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-22306489
5.
Investigation of intravenous delivery of nanoliposomal topotecan for activity against orthotopic glioblastoma xenografts.
Neuro Oncol
; 13(12): 1288-95, 2011 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-21954443
6.
Systemic and local drug delivery for treating diseases of the central nervous system in rodent models.
J Vis Exp
; (42)2010 Aug 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-20736920